HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SelCID-3

a phosphodiesterase type IV inhibitor

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Phthalic Acids: 1
      - Phthalimides: 12
        Thalidomide: 4688
        SelCID-3: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - Piperidones: 37
      - Thalidomide: 4688
        SelCID-3: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoindoles: 18
      - Phthalimides: 12
        Thalidomide: 4688
        SelCID-3: 1

Experts

1.	Childs, Kay: 1 article (02/2003)
2.	Clarke, Ian A: 1 article (02/2003)
3.	Czajka, Anna: 1 article (02/2003)
4.	Dalgleish, Angus G: 1 article (02/2003)
5.	Dredge, Keith: 1 article (02/2003)
6.	Govinda, Sowmya: 1 article (02/2003)
7.	Man, Hon-Wah: 1 article (02/2003)
8.	Marriott, J Blake: 1 article (02/2003)
9.	Muller, George W: 1 article (02/2003)
10.	Schafer, Peter: 1 article (02/2003)

Related Diseases

1.	Neoplasms (Cancer) 02/01/2003 - "Our results suggest that SelCID-3 represents a novel antitumor agent distinct from thalidomide and from previously characterized analogues with therapeutic potential against a range of solid tumors. "

Related Drugs and Biologics

1.	Thalidomide (Thalomid)
2.	Antineoplastic Agents (Antineoplastics)